Along the Road to 50 States, Steve Burden, founder and CEO of FACible Biodiagnostics, talks to Nigel about precision diagnostics and how precison medicine as a whole is the next big thing in pharma.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
We are a purpose-driven biodiagnostic technology company focused on helping people of all communities, understand and optimize their health with a new hospital-grade fast track test that offers speed, accessibility, and accuracy. Our proprietary Quantum-Logic Aptamer Analyte Detection (Q-LAAD) technology gives fast, accurate and affordable hospital-grade diagnostic tests for decision makers to make treatment decisions.
.svg)
